NOTCH GENE MUTATION POSITIVE TUMORS

Clinical trials for NOTCH GENE MUTATION POSITIVE TUMORS explained in plain language.

Never miss a new study

Get alerted when new NOTCH GENE MUTATION POSITIVE TUMORS trials appear

Sign up with your email to follow new studies for NOTCH GENE MUTATION POSITIVE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Last-Resort drug access for rare tumor patients

Disease control AVAILABLE

This program provides nirogacestat to individual patients with serious desmoid tumors or NOTCH gene mutation positive tumors who have no other treatment options and cannot join a clinical trial. The goal is to control the disease when standard therapies have failed. Approval is n…

Matched conditions: NOTCH GENE MUTATION POSITIVE TUMORS

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control

Last updated May 17, 2026 03:58 UTC

NOTCH GENE MUTATION POSITIVE TUMORS

Get alerted when new NOTCH GENE MUTATION POSITIVE TUMORS trials appear

Last-Resort drug access for rare tumor patients